Anthony Daniels
-
The Alliance for Eye and Vision Research honors two from VEI
Two Vanderbilt Eye Institute physicians have been selected as Emerging Vision Scientists by the Alliance for Eye and Vision Research (AEVR). Read MoreSep 8, 2016
-
Two receive Research to Prevent Blindness grants
Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology. Read MoreJul 21, 2016
-
Gifts highlight strong, lasting bonds between patients and healers
Sometimes saying thank you just isn’t enough. Read MoreMar 24, 2016
-
Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment
Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children. Read MoreJun 25, 2015
-
Novel therapy eases stress of retinoblastoma treatment
Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo. Read MoreOct 9, 2014